Scholarly Index
David A. Rizzieri
Novant Health; 17,503 total citations; 540 total publications; best world rank #365
Novant Health
17,503Total citations
540Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 404 | US 189 | 98.87 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 365 | US 197 | 98.53 |
| Lymphoma Diagnosis and Treatment | Lifetime | 779 | US 342 | 98.19 |
| Acute Lymphoblastic Leukemia research | Lifetime | 500 | US 245 | 98.15 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 798 | US 370 | 98.06 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 502 | US 237 | 97.76 |
| Neutropenia and Cancer Infections | Lifetime | 601 | US 266 | 95.20 |
| Polyomavirus and related diseases | Lifetime | 850 | US 401 | 94.21 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 755 | US 314 | 91.95 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 419 | US 156 | 83.73 |
| Neutropenia and Cancer Infections | 2021-2025 | 477 | US 167 | 77.91 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 940 | US 253 | 74.16 |